Surface Oncology SURF

$ 1.07 0.0%

Quarterly report 2023-Q2
added 08-02-2023

Surface Oncology Financial Statements 2011-2024 | SURF

Annual Financial Statements Surface Oncology

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	40.7 M	211 M	328 M	72.7 M	114 M	-	-	-	-	-	-	-
Shares	55.8 M	44.2 M	35.5 M	27.9 M	20 M	-	-	-	-	-	-	-
Historical Prices	0.73	4.78	9.24	1.88	4.24	-	-	-	-	-	-	-
Net Income	-63.6 M	-78.5 M	59.3 M	-54.8 M	-6.6 M	-45.4 M	-17.5 M	-	-	-	-	-
Revenue	30 M	2.69 M	126 M	15.4 M	59.4 M	12.8 M	6.63 M	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-61.9 M	-76 M	61.6 M	-57.4 M	-9.15 M	-46 M	-18 M	-	-	-	-	-
Interest Expense	3.15 M	2.55 M	2.86 M	145 K	-	-	-	-	-	-	-	-
EBITDA	-60.5 M	-74.4 M	63.3 M	-55.6 M	-7.8 M	-45 M	-17.7 M	-	-	-	-	-
Operating Expenses	91.9 M	78.7 M	64.6 M	72.7 M	68.6 M	-	-	-	-	-	-	-
General and Administrative Expenses	24.9 M	25.1 M	23.6 M	20.6 M	16.1 M	11 M	4.14 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Surface Oncology

	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	60.7 M	60.6 M	60.6 M	59.1 M	54.7 M	48.6 M	47 M	45.2 M	43.6 M	41.6 M	40.7 M	40 M	33.4 M	28 M	27.9 M	27.9 M	27.8 M	27.8 M	27.8 M	27.6 M	21.6 M	2.73 M	2.69 M	2.51 M	2.41 M	2.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-28.2 M	-19.7 M	-	-23.2 M	-25.2 M	6.2 M	-	-19.9 M	-19 M	-15.6 M	67.3 M	-15.8 M	-14.8 M	22.6 M	-16 M	-16.9 M	-17.8 M	-4.2 M	-4.74 M	-17.2 M	-15.9 M	31.2 M	-15.8 M	-14.4 M	-6.57 M	-8.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	30 M	-	392 K	515 K	1.63 M	87.6 M	-	-	38.6 M	439 K	344 K	143 K	14.4 M	9.76 M	1.73 M	2.43 M	45.5 M	2.48 M	2.48 M	6.2 M	1.67 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-25.6 M	-19.7 M	-	-22.9 M	-24.6 M	6.84 M	-	-19.5 M	-18.6 M	-14.6 M	68 M	-14.4 M	-14.5 M	22.5 M	-16.3 M	-17.6 M	-18.5 M	-4.97 M	-5.58 M	-18 M	-16.6 M	31 M	-16.6 M	-14.3 M	-6.53 M	-8.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	3.11 M	932 K	-	829 K	733 K	682 K	-	421 K	416 K	1.02 M	-	1.47 M	427 K	340 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-19.3 M	-	-21.9 M	-24.6 M	7.18 M	-	-18.3 M	-18.6 M	-14.2 M	68 M	-13.1 M	-13.7 M	23 M	-16.3 M	-16.2 M	-17.6 M	-4.54 M	-5.58 M	-17 M	-15.9 M	31.4 M	-16.6 M	-13.6 M	-6.13 M	-8.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	25.6 M	19.7 M	-	22.9 M	24.6 M	23.2 M	-	19.9 M	19.1 M	16.2 M	19.6 M	14.4 M	14.5 M	16.1 M	16.8 M	17.9 M	18.7 M	19.4 M	15.3 M	19.8 M	19 M	14.5 M	19.1 M	16.8 M	12.7 M	10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	8.58 M	5.89 M	-	6 M	6.43 M	6.54 M	-	5.85 M	6.43 M	5.64 M	-	4.9 M	5 M	4.79 M	-	4.98 M	5.42 M	5.09 M	-	3.98 M	3.91 M	3.36 M	-	4.65 M	2 M	1.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency